LGALS3 and T-cell leukemia: Treatment of CD4 CD8 double-negative T-cells, T-cell leukemia, diffuse large B cell lymphoma and colon cancer cell lines for 4–48 hours with 300–15000 nM Galectin-3 was reported to result in apoptosis of the recipient cells [39–42].